請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/44572
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林中天(Chung-Tien Lin) | |
dc.contributor.author | Hsiao-Lei Lee | en |
dc.contributor.author | 李筱蕾 | zh_TW |
dc.date.accessioned | 2021-06-15T03:51:15Z | - |
dc.date.available | 2012-07-22 | |
dc.date.copyright | 2010-07-22 | |
dc.date.issued | 2010 | |
dc.date.submitted | 2010-07-13 | |
dc.identifier.citation | Blogg JR. Disease of the cornea. In: Blogg JR, ed. The eye in veterinary practice: extraocular disease. Saunders, 375-382, 1980.
Borazan M, Karalezli A, Oto S, Akova YA, Karabay G, Kocbiyik A, Celasun B, and Demirhan B. Induction of apoptosis of rabbit corneal endothelial cells by preservative-free lidocaine hydrochloride 2%, ropivacaine 1%, or levobupivacaine 0.75%. J Cataract Refract Surg 35: 753-758, 2009. Chang SW. Early corneal edema following topical application of mitomycin-C. J Cataract Refract Surg 30: 1742-1750, 2004. Chang YS, Tseng SY, Tseng SH, and Wu CL. Cytotoxicity of lidocaine or bupivacaine on corneal endothelial cells in a rabbit model. Cornea 25: 590-596, 2006. Chen WL, Hu FR, Wang IJ, and Chang HW. Surgical results of photorefractive keratectomy with different operative modes. J Cataract Refract Surg 26: 879-886, 2000. Demir MN, Demir ZA, Yalcin Tok O, Yilmaz FM, Yilmaz G, Nurozler AB, and Ornek F. Oxidative stress of intracameral Lidocaine and Levobupivacaine on ocular tissues. Br J Ophthalmol 2009. Ding Y, Bushell A, and Wood KJ. Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantation. Transplantation 89: 270-273, 2010. Du Y, Carlson EC, Funderburgh ML, Birk DE, Pearlman E, Guo N, Kao WW, and Funderburgh JL. Stem cell therapy restores transparency to defective murine corneas. Stem cells (Dayton, Ohio) 27: 1635-1642, 2009. Flynn TH, Ohbayashi M, Dawson M, Siddique M, Ono SJ, and Larkin DF. Use of ultrasonic pachymetry for measurement of changes in corneal thickness in mouse corneal transplant rejection. Br J Ophthalmol 94: 368-371, 2010. Fu YS, Cheng YC, Lin MY, Cheng H, Chu PM, Chou SC, Shih YH, Ko MH, and Sung MS. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem cells (Dayton, Ohio) 24: 115-124, 2006. Gelatt KN, and Gelatt JP. Surgery of the cornea and sclera. In: Gelatt KN, ed. Small animal ophthalmic surgery: Practical techniques for the veterinarian. Butterworth-Heinnemann, 202-213, 2001. Gilger BC, Whitley RD, McLaughlin SA, Wright JC, and Drane JW. Canine corneal thickness measured by ultrasonic pachymetry. Am J Vet Res 52: 1570-1572, 1991. Gilger BC, Wright JC, Whitley RD, and McLaughlin SA. Corneal thickness measured by ultrasonic pachymetry in cats. Am J Vet Res 54: 228-230, 1993. Glaze MB. Ophthalmic disease and its management. Vet clin North Am, Small anim pract 27: 1505-1521, 1997. Gospodarowicz D, Greenburg G, and Alvarado J. Transplantation of cultured bovine corneal endothelial cells to rabbit cornea: clinical implications for human studies. Proc Natl Acad Sci U S A 76: 464-468, 1979. Gospodarowicz D, Greenburg G, and Alvarado J. Transplantation of cultured bovine corneal endothelial cells to species with nonregenerative endothelium. The cat as an experimental model. Arch Ophthalmol 97: 2163-2169, 1979. Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, and Simmons PJ. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116: 1827-1835, 2003. Hayashi T, Yamagami S, Tanaka K, Yokoo S, Usui T, Amano S, and Mizuki N. A mouse model of allogeneic corneal endothelial cell transplantation. Cornea 27: 699-705, 2008. Hayashi T, Yamagami S, Tanaka K, Yokoo S, Usui T, Amano S, and Mizuki N. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site. Investigative ophthalmology & visual science 50: 3151-3158, 2009. Hever AM, Williamson KA, and van Heyningen V. Developmental malformations of the eye: the role of PAX6, SOX2 and OTX2. Clin Genet 69: 459-470, 2006. Hitani K, Yokoo S, Honda N, Usui T, Yamagami S, and Amano S. Transplantation of a sheet of human corneal endothelial cell in a rabbit model. Molecular vision 14: 1-9, 2008. Honda N, Mimura T, Usui T, and Amano S. Descemet stripping automated endothelial keratoplasty using cultured corneal endothelial cells in a rabbit model. Arch Ophthalmol 127: 1321-1326, 2009. Hsiue GH, Lai JY, Chen KH, and Hsu WM. A novel strategy for corneal endothelial reconstruction with a bioengineered cell sheet. Transplantation 81: 473-476, 2006. Joyce NC. Proliferative capacity of the corneal endothelium. Prog Retin Eye Res 22: 359-389, 2003. Klebe S, Coster DJ, and Williams KA. Rejection and acceptance of corneal allografts. Current opinion in organ transplantation 14: 4-9, 2009. Koizumi N, Sakamoto Y, Okumura N, Tsuchiya H, Torii R, Cooper LJ, Ban Y, Tanioka H, and Kinoshita S. Cultivated corneal endothelial transplantation in a primate: possible future clinical application in corneal endothelial regenerative medicine. Cornea 27 Suppl 1: S48-55, 2008. Lai JY, Chen KH, and Hsiue GH. Tissue-engineered human corneal endothelial cell sheet transplantation in a rabbit model using functional biomaterials. Transplantation 84: 1222-1232, 2007. Lai JY, Chen KH, Hsu WM, Hsiue GH, and Lee YH. Bioengineered human corneal endothelium for transplantation. Arch Ophthalmol 124: 1441-1448, 2006. Landshman N, Ben-Hanan I, Assia E, Ben-Chaim O, and Belkin M. Relationship between morphology and functional ability of regenerated corneal endothelium. Invest Ophthalmol Vis Sci Jul;29(7): 1100-1109, 1988. Li TZ, Kim JH, Cho HH, Lee HS, Kim KS, Lee SW, and Suh H. Therapeutic Potential of Bone Marrow-derived Mesenchymal Stem Cells Differentiated with Growth Factor-free Co-culture Method in Liver-Injured Rats. Tissue Eng Part A 2010. Macdonald JM, Geroski DH, and Edelhauser HF. Effect of inflammation on the corneal endothelial pump and barrier. Curr Eye Res 6: 1125-1132, 1987. Maggas DJ MP, Ofri R. Slatter's Fundamentals of Veterinary Ophthalmology. Saunders Elsevier, 2008. Maggs DJ. Cornea and sclera. In: Maggs DJ, Miller PE, Ofri R, and Slatter DH, ed. Slatter's fundamentals of veterinary ophthalmology. Saunders Elsevier, St. Louis, Mo., 175-202, 2008. McGowan SL, Edelhauser HF, Pfister RR, and Whikehart DR. Stem cell markers in the human posterior limbus and corneal endothelium of unwounded and wounded corneas. Molecular vision 13: 1984-2000, 2007. Melles GR, Ong TS, Ververs B, and van der Wees J. Descemet membrane endothelial keratoplasty (DMEK). Cornea 25: 987-990, 2006. Melles GR, Wijdh RH, and Nieuwendaal CP. A technique to excise the descemet membrane from a recipient cornea (descemetorhexis). Cornea 23: 286-288, 2004. Michau TM, Gilger BC, Maggio F, and Davidson MG. Use of thermokeratoplasty for treatment of ulcerative keratitis and bullous keratopathy secondary to corneal endothelial disease in dogs: 13 cases (1994–2001). JAVMA 222: 607-612, 2003. Miki T, Lehmann T, Cai H, Stolz DB, and Strom SC. Stem cell characteristics of amniotic epithelial cells. Stem cells (Dayton, Ohio) 23: 1549-1559, 2005. Mimura T, Yamagami S, Usui T, Seiichi, Honda N, and Amano S. Necessary prone position time for human corneal endothelial precursor transplantation in a rabbit endothelial deficiency model. Curr Eye Res 32: 617-623, 2007. Mimura T, Yamagami S, Yokoo S, Usui T, Tanaka K, Hattori S, Irie S, Miyata K, Araie M, and Amano S. Cultured human corneal endothelial cell transplantation with a collagen sheet in a rabbit model. Investigative ophthalmology & visual science 45: 2992-2997, 2004. Mimura T, Yamagami S, Yokoo S, Yanagi Y, Usui T, Ono K, Araie M, and Amano S. Sphere therapy for corneal endothelium deficiency in a rabbit model. Investigative ophthalmology & visual science 46: 3128-3135, 2005. Mimura T, Yokoo S, Araie M, Amano S, and Yamagami S. Treatment of rabbit bullous keratopathy with precursors derived from cultured human corneal endothelium. Investigative ophthalmology & visual science 46: 3637-3644, 2005. Mitchell KE, Weiss ML, Mitchell BM, Martin P, Davis D, Morales L, Helwig B, Beerenstrauch M, Abou-Easa K, Hildreth T, Troyer D, and Medicetty S. Matrix cells from Wharton's jelly form neurons and glia. Stem cells (Dayton, Ohio) 21: 50-60, 2003. Montiani-Ferreira F, Cardoso F, and Petersen-Jones S. Postnatal development of central corneal thickness in chicks of Gallus gallus domesticus. Veterinary ophthalmology 7: 37-39, 2004. Morales AJ, Zadok D, Mora-Retana R, Martinez-Gama E, Robledo NE, and Chayet AS. Intraoperative mitomycin and corneal endothelium after photorefractive keratectomy. Am J Ophthalmol 142: 400-404, 2006. Nuyts RM, Pels E, and Greve EL. The effects of 5-fluorouracil and mitomycin C on the corneal endothelium. Curr Eye Res 11: 565-570, 1992. Park J, Koito H, Li J, and Han A. A multi-compartment CNS neuron-glia Co-culture microfluidic platform. J Vis Exp 2009. Pindjakova J, Vitova A, Krulova M, Zajicova A, Filipec M, and Holan V. Corneal rat-to-mouse xenotransplantation and the effects of anti-CD4 or anti-CD8 treatment on cytokine and nitric oxide production. Transpl Int 18: 854-862, 2005. Pirnia F, Schneider E, Betticher DC, and Borner MM. Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathway. Cell Death Differ 9: 905-914, 2002. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, and Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147, 1999. Price MO, and Price FW. Descemet's stripping endothelial keratoplasty. Current opinion in ophthalmology 18: 290-294, 2007. Rodrigues GN, Laus JL, Santos JM, Rigueiro MP, and Smith RL. Corneal endothelial cell morphology of normal dogs in different ages. Veterinary ophthalmology 9: 101-107, 2006. Rossignol J, Boyer C, Thinard R, Remy S, Dugast AS, Dubayle D, Dey ND, Boeffard F, Delecrin J, Heymann D, Vanhove B, Anegon I, Naveilhan P, Dunbar GL, and Lescaudron L. Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation. J Cell Mol Med 13: 2547-2558, 2009. Ryu S, and Albert DM. Evaluation of tumor angiogenesis factor with the rabbit cornea model. Investigative ophthalmology & visual science 18: 831-841, 1979. Samuelson DA. Ophthalmic anatomy. In: Gelatt KN, ed. Veterinary ophthalmology. Lippincott Williams&Wilkins, 31-60, 1999. Schneider RK, Pullen A, Kramann R, Bornemann J, Knuchel R, Neuss S, and Perez-Bouza A. Long-term survival and characterisation of human umbilical cord-derived mesenchymal stem cells on dermal equivalents. Differentiation 79: 182-193, 2010. Schugar RC, Chirieleison SM, Wescoe KE, Schmidt BT, Askew Y, Nance JJ, Evron JM, Peault B, and Deasy BM. High harvest yield, high expansion, and phenotype stability of CD146 mesenchymal stromal cells from whole primitive human umbilical cord tissue. J Biomed Biotechnol 2009: 789526, 2009. Sonmez B, Kim BT, and Aldave AJ. Amniotic membrane transplantation with anterior stromal micropuncture for treatment of painful bullous keratopathy in eyes with poor visual potential. Cornea 26: 227-229, 2007. Stades FC. Cornea and sclera. In: Stades FC, Wyman M, Boeve MH, Neumann W, and Spiess B, ed. Ophthalmology for the veterinary practitioner. Blackwell, Oxford, 2007. Swartz T, Marten L, and Wang M. Measuring the cornea: the latest developments in corneal topography. Current opinion in ophthalmology 18: 325-333, 2007. Takacs L, Toth E, Berta A, and Vereb G. Stem cells of the adult cornea: from cytometric markers to therapeutic applications. Cytometry A 75: 54-66, 2009. Takahashi H. Free radical development in phacoemulsification cataract surgery. J Nippon Med Sch 72: 4-12, 2005. van der Woerdt A, Gilger BC, Wilkie DA, and Strauch SM. Effect of auriculopalpebral nerve block and intravenous administration of xylazine on intraocular pressure and corneal thickness in horses. Am J Vet Res 56: 155-158, 1995. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, and Chen CC. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem cells (Dayton, Ohio) 22: 1330-1337, 2004. Wu KY, Hong SJ, Huang HT, Lin CP, and Chen CW. Toxic effects of mitomycin-C on cultured corneal keratocytes and endothelial cells. J Ocul Pharmacol Ther 15: 401-411, 1999. Wu KY, Wang HZ, and Hong SJ. Mechanism of mitomycin-induced apoptosis in cultured corneal endothelial cells. Molecular vision 14: 1705-1712, 2008. Yee RW, Geroski DH, Matsuda M, Champeau EJ, Meyer LA, and Edelhauser HF. Correlation of corneal endothelial pump site density, barrier function, and morphology in wound repair. Invest Ophthalmol Vis Sci Sep;26(9): 1191-1201, 1985 Yokoo S, Yamagami S, Yanagi Y, Uchida S, Mimura T, Usui T, and Amano S. Human corneal endothelial cell precursors isolated by sphere-forming assay. Investigative ophthalmology & visual science 46: 1626-1631, 2005. 傅瑤, 范先群, 羅敏, and 陳萍. 羊膜載體培養標記兔角膜內皮細胞移植的研究. Chin J Ophthalmol 42: 925-929, 2006. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/44572 | - |
dc.description.abstract | 在人類、非人靈長類、以及犬貓的角膜內皮細胞再生能力有限,而角膜內皮細胞含有Na+/K+ ATPase 幫浦,對於維持角膜的透明度和控制角膜含水量有很大的重要性。因此若無法代償便會產生角膜水腫,唯有角膜移植手術能有效改善,然而全球都有角膜來源欠缺及移植後排斥反應的問題存在。人類臍帶間質幹細胞(human umbilical mesenchymal stem cells, HUMSCs)在近年來已被證明含有許多種分化潛能,而且在體外能以不同細胞培養環境來誘導,可應用在再生醫學方面。然而目前並沒有任何研究證明臍帶間質幹細胞可以分化為角膜內皮細胞。
本研究評估以HUMSC治療白兔角膜內皮細胞缺損之潛能,以兩種方式於紐西蘭白兔測試並建立眼角膜內皮細胞缺損的動物模式,包括眼前房注射mitomycin-C (MMC)及角膜彈力層刮除術,以模擬在人類和多數動物角膜內皮缺損的情形。結果顯示刮除術組能維持角膜混濁第4級,更可有效建立長久的重度角膜內皮缺損,然而MMC組方面只能達到中等程度的水腫,維持約少於一個月的角膜內皮缺損。HUMSC的移植採用細胞懸浮液(1x107 cell/μl)前房注射的方式,並在術後保持側臥姿6小時,角膜上皮朝下的方式以重力幫助移植細胞服貼於角膜內層。觀察其治療失償性水腫的效果,結果顯示臨床上角膜水腫情形並未改善;病理評估後發現,HUMSC移植後能存活但往多方面分化,如虹膜上皮、類似睫狀體的增生組織和肉芽腫。其中處於前房和虹膜的密集細胞團塊,因其細胞核質比高並出現有絲分裂,高度懷疑為HUMSC。此外CD31與VEGF染色證實有血管增生的情形。顯示雖然移植後的HUMSC能存活並保有分化能力,但有可能HUMSC分化成同樣是神經脊來源的間質組織。而以CFDA-SE測試體外標定HUMSC,結果顯示持續時期過短,螢光在約維持一周後便逐漸衰弱,而無法做為追蹤移植後HUMSC的細胞數量和位置。 | zh_TW |
dc.description.abstract | The ability of human, nonhuman primate, canine and feline corneal endothelium to proliferate is severely limited, and corneal endothelial cells hold Na+/K+ ATPase and contribute to the maintenance of the corneal transparency by their pump and barrier functions. Therefore, decompensation of endothelium would produce corneal edema. Keratoplasty is the only effective treatment for endothelial dysfunction, but there is a worldwide shortage of human donor corneas. Human umbilical mesenchymal stem cells (HUMSCs) have the potential to develop into multicells in different ex vivo culture environment, improving regenerative medicine. However, there is no evidence to prove HUMSCs could differentiate into corneal endothelium.
Hence, the objective of this study was to investigate the potential of HUMSCs transplantation to treat rabbit corneal endothelium deficiency edema. To create an animal model of corneal endothelium deficiency in New Zealand white rabbit, Mitomycin-C (MMC) anterior chamber injection and descemetohexis were used to enable the mimicking of human cornea. While descemetohexis group resulted in permanent defect of endothelium with corneal haze grade 4, the MMC group only maintained moderate cornea endothelium deficiency less than a month. HUMSCs were transplanted by the injection into anterior chamber in cell suspension (1x107 cell /μl). After transplantation, rabbits were kept in the prone position (epithelium down) for 6 hours, to improve HUMSC attachment to posterior cornea by gravity. As a result, post-transplantation did not decrease clinical corneal edema level, and histological examination revealed that dense cell clusters resided in the anterior chamber and iris. Given the fact that they possessed high N/C ratio and mitosis, it is highly suspected that the dense cell clusters were the transplanted HUMSCs. The HUMSCs survived and differentiated into various kinds of cells, and sequentially proliferated into iris epithelium and ciliary body-like tissue, in which CD31 and VEGF stain showed angiogenesis. The finding of this study also suggested that HUMSCs can survive after anterior chamber transplantation, and possess differentiation capacity. Thus, HUMSCs may have the potential to differentiate into various cells originating from the neural crest-derived mesenchymal tissue. Another discovery made by the study is the ex vivo labeled HUMSCs with CFDA-SE resulted in gradually weaker fluorescent after one week, a reason why CFDA-SE is probably not a suitable marker to trace the number and location of transplanted HUMSCs. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T03:51:15Z (GMT). No. of bitstreams: 1 ntu-99-R96643001-1.pdf: 2074495 bytes, checksum: 5bed398e35f63863102863e78e142c6c (MD5) Previous issue date: 2010 | en |
dc.description.tableofcontents | 目錄
口試委員會審定書 i 誌謝 ii 中文摘要 iii 英文摘要 v 第一章 緒言 1 第一節 角膜內皮失償性水腫 1 第二節 角膜內皮細胞失償性水腫之治療 2 第三節 臍帶間質幹細胞在角膜水腫治療之潛能 2 第四節 研究目的 2 第二章文獻探討 4 第一節 角膜內皮細胞失償性水腫之生理機制及造成原因 4 一、生理機制 4 二、造成病因 6 第二節 人、犬貓角膜內皮細胞失償性水腫之治療方式 7 一、內科療法 7 二、外科療法 8 三、角膜內皮植體來源 9 第三節 角膜內皮細胞失償性水腫之動物模式 11 一、MMC破壞角膜內皮細胞之機制 12 第四節 幹細胞在角膜病變之應用 13 第五節 臍帶間質幹細胞之潛能與應用 14 第六節 間質幹細胞標定法 15 第三章 實驗材料與方法 17 第一節 動物模式 17 第二節 角膜內皮細胞缺損模式 17 一、注射Mitomycin-C 17 二、角膜彈力層刮除(Scraping or Descemetorhexis) 18 第三節 臍帶間質幹細胞 19 一、臍帶間質幹細胞細胞株 19 二、臍帶間質幹細胞培養方法與備製 19 三、臍帶間質幹細胞的標定方法 21 四、臍帶間質幹細胞的注射法 21 第四節 羊膜細胞培養方式 22 第五節 角膜混濁之紀錄與分級 23 第六節 組織病理學切片評估 23 第四章 實驗結果 26 第一節 角膜內皮細胞缺損模式 26 一、臨床觀察 26 二、組織病理檢查 26 第二節 臍帶間質幹細胞的標定結果 27 第三節 羊膜細胞的標定結果 28 第四節 臍帶間質幹細胞注射後的效果 28 一、臨床觀察 28 二、組織病理檢查 29 第五章 討論 31 第一節 角膜內皮細胞缺損模式之選擇與比較 31 一、Mitomycin-C對角膜內皮之傷害 31 二、角膜彈力層刮除術 32 第二節 角膜水腫傷害的病理變化 32 第三節 評估HUMSC移植的效果 34 第四節 移植效果與文獻比較 35 第五節 角膜移植免疫與排斥 36 第六節 未來展望 37 第六章 結論 39 第七章 參考文獻 40 圖目錄 46 表目錄 66 | |
dc.language.iso | zh-TW | |
dc.title | 以人類臍帶間質幹細胞做為角膜內皮失償性水腫的細胞療法 | zh_TW |
dc.title | Cell Therapy of Corneal Endothelium Deficiency with Human Umbilical Mesenchymal Stem Cells | en |
dc.type | Thesis | |
dc.date.schoolyear | 98-2 | |
dc.description.degree | 碩士 | |
dc.contributor.coadvisor | 陳偉勵(Wei-Li Chen) | |
dc.contributor.oralexamcommittee | 詹東榮(Tong-Rong Jan),劉振軒(Chen-Hsuan Liu) | |
dc.subject.keyword | 角膜內皮細胞,角膜水腫,彈力層刮除術,幹細胞, | zh_TW |
dc.subject.keyword | corneal endothelium,corneal edema,descemetohexis,stem cell, | en |
dc.relation.page | 72 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2010-07-14 | |
dc.contributor.author-college | 獸醫專業學院 | zh_TW |
dc.contributor.author-dept | 臨床動物醫學研究所 | zh_TW |
顯示於系所單位: | 臨床動物醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-99-1.pdf 目前未授權公開取用 | 2.03 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。